Last 47 quarters of trend data · Consumer Defensive · Non-Alcoholic Beverages
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.02 | — | — | — | 1.40 | — | 0.39 | — | — | 1.01 | — | — | — | 1.62 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | -37.5% | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.05 | 0.16 | 0.43 | 0.75 | 0.91 | 1.01 | 0.85 | 1.66 | 0.61 | 0.82 | 0.76 | 0.86 | 0.88 | 1.02 | 1.31 | 1.67 | 2.06 | 1.44 | 2.41 | 2.66 | 4.83 |
| — | -84.1% | -49.2% | -54.7% | +50.9% | +23.2% | +10.9% | +93.3% | -31.0% | -19.1% | -41.8% | -48.5% | -57.5% | -29.3% | -45.7% | -37.2% | -57.3% | -87.5% | -84.8% | +122.7% | -79.8% | |
| P/B Ratio | 0.05 | 1.47 | 0.65 | 0.65 | 0.87 | 1.30 | 0.46 | 1.30 | 0.37 | 0.37 | 0.29 | 0.32 | 0.30 | 0.30 | 0.39 | 0.32 | 0.52 | 0.83 | 1.03 | 0.74 | 1.14 |
| — | +12.9% | +43.6% | -49.6% | +138.4% | +250.2% | +58.7% | +310.0% | +24.0% | +24.9% | -25.8% | -0.9% | -42.9% | -64.1% | -62.3% | -56.8% | -54.6% | -45.2% | -10.5% | -37.9% | -54.4% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | -0.08 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | 1.06 | — | 0.09 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.2% | 43.7% | 36.4% | 21.3% | 32.1% | 43.4% | 43.2% | 32.0% | 32.9% | 51.5% | 52.3% | 42.7% | 37.0% | 49.9% | 44.2% | -55.2% | 28.2% | 10.7% | -7.4% | -72.9% | -5.7% |
| — | +0.8% | -15.8% | -33.4% | -2.3% | -15.8% | -17.4% | -25.1% | -11.2% | +3.3% | +18.4% | +177.4% | +31.4% | +368.3% | +697.4% | +24.3% | +595.5% | +182.2% | -118.6% | -196.4% | +98.8% | |
| Operating Margin | -205.7% | -34.4% | -70.8% | -152.6% | -108.2% | -411.7% | -101.7% | -187.4% | -114.5% | 151.6% | -160.9% | -287.5% | -107.6% | -112.1% | -313.9% | -583.0% | -254.2% | -98.1% | -143.6% | -635.8% | -366.7% |
| — | +91.7% | +30.3% | +18.6% | +5.5% | -371.5% | +36.8% | +34.8% | -6.4% | +235.2% | +48.7% | +50.7% | +57.7% | -14.3% | -118.6% | +8.3% | +30.7% | +82.1% | +77.7% | -707.0% | +84.8% | |
| Net Margin | -48.1% | -434.2% | -398.6% | -148.3% | 65.7% | -306.4% | 216.6% | -334.2% | -104.9% | 81.2% | -245.5% | -243.8% | -197.8% | 63.5% | -761.7% | -424.4% | -182.6% | -97.9% | -139.4% | -427.5% | -91.5% |
| — | -41.7% | -284.1% | +55.6% | +162.7% | -477.1% | +188.2% | -37.1% | +47.0% | +28.0% | +67.8% | +42.5% | -8.3% | +164.8% | -446.5% | +0.7% | -99.5% | +73.9% | -156.1% | -442.6% | +95.5% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -45.1% | -356.2% | -124.8% | -27.9% | 17.2% | -66.3% | 34.4% | -49.6% | -14.8% | 9.6% | -20.9% | -20.3% | -15.5% | 4.8% | -49.9% | -18.5% | -11.1% | -13.3% | -14.6% | -26.0% | -5.2% |
| — | -436.9% | -463.3% | +43.8% | +215.6% | -789.4% | +264.4% | -144.5% | +4.2% | +101.3% | +58.1% | -9.8% | -40.0% | +136.1% | -241.7% | +28.9% | -111.0% | -11.3% | -363.6% | -159.2% | +89.5% | |
| ROA | -23.3% | -111.7% | -73.9% | -17.7% | 10.5% | -42.9% | 19.6% | -28.3% | -9.9% | 6.4% | -13.6% | -13.2% | -10.2% | 2.9% | -31.6% | -13.4% | -8.3% | -10.2% | -10.9% | -18.0% | -3.3% |
| — | -160.4% | -476.8% | +37.5% | +205.8% | -775.7% | +244.7% | -113.8% | +3.2% | +120.7% | +57.1% | +1.3% | -23.8% | +128.1% | -191.5% | +25.6% | -146.7% | -37.7% | -411.5% | -182.1% | +81.2% | |
| ROIC | -249.2% | — | -20.1% | -25.1% | -28.2% | -100.6% | -23.2% | -39.3% | -20.0% | 20.3% | -15.7% | -38.1% | -17.7% | -176.0% | — | -128.1% | -47.6% | -34.5% | -48.7% | -144.7% | -86.4% |
| — | — | +13.2% | +36.1% | -41.0% | -595.1% | -47.6% | -3.2% | -12.9% | +111.5% | — | +70.3% | +62.8% | -410.7% | — | +11.5% | +44.9% | +20.3% | -167.5% | -554.4% | -44.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | 0.00 | 0.00 | 0.02 | 0.03 | 0.05 | 0.08 | 0.08 | 0.08 | 0.09 | 0.11 | 0.10 | 0.09 | 0.09 | 0.09 | 0.11 | 0.09 |
| — | — | — | — | — | -95.1% | -97.0% | -68.6% | -58.7% | -42.3% | -26.2% | -17.9% | -8.4% | -7.7% | +17.1% | -8.6% | -4.8% | -49.8% | -42.1% | -67.8% | -88.1% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | 0.29 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.09 | 3.49 | 3.79 | 3.09 | 3.67 | 4.12 | 3.99 | 3.61 | 4.60 | 4.61 | 4.05 | 4.17 | 5.15 | 5.70 | 6.64 | 6.03 | 7.41 | 6.34 | 6.55 | 7.02 | 6.76 |
| — | -15.4% | -5.1% | -14.4% | -20.2% | -10.6% | -1.3% | -13.5% | -10.7% | -19.2% | -39.1% | -30.9% | -30.5% | -10.0% | +1.4% | -14.1% | +9.7% | -4.7% | -35.0% | +39.9% | +168.0% | |
| Quick Ratio | 2.50 | 2.92 | 3.17 | 2.50 | 3.03 | 3.31 | 3.41 | 3.25 | 4.24 | 4.25 | 3.41 | 3.94 | 4.47 | 4.93 | 6.01 | 5.48 | 6.59 | 5.65 | 5.88 | 6.14 | 5.92 |
| — | -11.8% | -7.1% | -23.2% | -28.5% | -22.0% | +0.1% | -17.4% | -5.0% | -13.9% | -43.3% | -28.2% | -32.2% | -12.7% | +2.2% | -10.7% | +11.4% | -8.1% | -38.8% | +39.1% | +322.3% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -4982.00 | -12.48 | -499.00 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying RKDA stock.
Arcadia Biosciences, Inc.'s current P/E is -0.0x. The average P/E over the last 1 quarters is 1.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Arcadia Biosciences, Inc.'s current operating margin is -205.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Arcadia Biosciences, Inc.'s business trajectory between earnings reports.